title: Reply to: "Frequent plasma cell hepatitis during telaprevir-based triple therapy for hepatitis C after liver transplantation".
authors: AP-HP, Hôpital Paul Brousse, Centre hépato-Biliaire, Villejuif, France; Inserm, Unité 785, Villejuif, France; Univ Paris-Sud, Villejuif, France; DHU Hepatinov, Villejuif, France. Electronic address: audrey.coilly@pbr.aphp.fr.
authors: Audrey
authors: A
authors: Coilly
authors: AP-HP, Hôpital Paul Brousse, Centre hépato-Biliaire, Villejuif, France; Inserm, Unité 785, Villejuif, France; Univ Paris-Sud, Villejuif, France; DHU Hepatinov, Villejuif, France.
authors: Mylène
authors: M
authors: Sebagh
authors: AP-HP, Hôpital Paul Brousse, Centre hépato-Biliaire, Villejuif, France; Inserm, Unité 785, Villejuif, France; Univ Paris-Sud, Villejuif, France; DHU Hepatinov, Villejuif, France.
authors: Jean-Charles
authors: JC
authors: Duclos-Vallée
mesh_terms: D005260:Female; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D016031:Liver Transplantation; D008297:Male; D011480:Protease Inhibitors / Q000627:therapeutic use*
chemical_list: D011480:Protease Inhibitors